What do the numbers say about Tata Chemicals Ltd. (TATACHEM)? Here's a look at its financials, valuation, and ownership data.
Tata Chemicals Revenue Trend
Top-line pressure showed for Tata Chemicals Ltd., with revenue declining 3.8% to ₹15,112 Cr in FY2025.
Over the past 10 years, revenue has declined at a 1.3% annual rate, from ₹17,203 Cr to ₹15,112 Cr. A slow bleed, but still a declining trend.
Tata Chemicals Ltd.'s ₹15,112 Cr revenue base puts it in the major bracket among chemicals - inorganic companies in India.
| Year | Revenue | YoY % |
|---|---|---|
| FY2025 | ₹15,112 Cr | -3.8% |
| FY2024 | ₹15,707 Cr | -7.6% |
| FY2023 | ₹17,007 Cr | +32.1% |
| FY2022 | ₹12,878 Cr | +26.3% |
| FY2021 | ₹10,200 Cr | — |
View Tata Chemicals Ltd.'s full 10-year revenue trend with CAGR analysis →
Tata Chemicals Profitability
A 11.0% decline brought Tata Chemicals Ltd.'s net profit down to ₹387 Cr in FY2025 from ₹435 Cr.
Margins stayed in a tight range, with net profit margin at 2.6% in FY2025.
Per-share earnings moved to ₹9.23 in FY2025 from ₹10.52 in FY2024.
Is Tata Chemicals Undervalued
The P/E Ratio valuation pegs Tata Chemicals Ltd.'s fair value at ₹748, which is 4.0% upside from the current price.
Tata Chemicals Ltd. shares are currently trading at ₹719.75.
Craytheon also calculates intrinsic value using the EPS Growth model. The full breakdown with assumptions is available in the detailed analysis.
| Model | Est. Fair Value | vs. Current Price |
|---|---|---|
| P/E Ratio | ₹748 | 4.0% upside to fair value |
| EPS Growth | Upgrade | Upgrade |
See all valuation models for Tata Chemicals Ltd. with detailed assumptions →
Tata Chemicals Shareholding Pattern
Promoter holding is steady at 38.0% — no buying or selling over the past 4 quarters.
Foreign investors held 12.3% of the company as of December 2025, down year-over-year from 13.3%.
DII holding is at 22.4%, up from 22.0% in the year-ago quarter.
| Quarter | Promoter | FII | DII | Public |
|---|---|---|---|---|
| Dec 2025 | 38.0% | 12.3% | 22.4% | 27.3% |
| Sep 2025 | 38.0% | 13.7% | 22.2% | 26.1% |
| Jun 2025 | 38.0% | 12.8% | 22.6% | 26.5% |
| Mar 2025 | 38.0% | 13.3% | 22.0% | 26.7% |
Track quarterly shareholding changes for Tata Chemicals Ltd. →
Tata Chemicals Balance Sheet
Proportional view as of 3 Jun 2026. Hover blocks for details.
Assets
Liabilities & Equity
Total assets stood at ₹377.80B at the end of FY2025, up 2.8% from ₹367.56B a year earlier.
Intangibles & Goodwill is the largest block at 28.5%, followed by Property, Plant & Equipment at 26.3% and Investments at 22.1%.
Equity makes up 59.6% of liabilities and equity, with debt at 18.7% and operating liabilities at 21.7%. Over the year, debt is up 27.1% and equity is down 2.7%.
Balance sheet composition — FY 2025
| Category | Value |
|---|---|
| Cash & ST Investments | 13.53B |
| Receivables | 19.00B |
| Inventories | 25.58B |
| Property, Plant & Equipment | 99.52B |
| Investments | 83.39B |
| Intangibles & Goodwill | 107.56B |
| Other Assets | 29.22B |
| Category | Value |
|---|---|
| Equity | 225.01B |
| Short-term Debt | 22.56B |
| Long-term Debt | 48.16B |
| Trade Payables | 25.10B |
| Other Liabilities | 56.97B |
Tata Chemicals — The Bottom Line
Bringing the key threads together for Tata Chemicals Ltd. (TATACHEM) as a chemicals - inorganic investment opportunity.
Revenue of ₹15,112 Cr in FY2025, down 3.8% year-over-year.
Long-term revenue has been contracting at 1.3% annually over 10 years.
The company is profitable, with a net margin of 2.6% and net income of ₹387 Cr.
The P/E Ratio model implies 4.0% upside to fair value from the current price. The remaining two models are worth cross-checking before drawing a conclusion — sign up to see the full analysis.
Unlock Full Analysis
Want to dig deeper? Craytheon's platform provides 10 years of financial data, three valuation models, and insider trading activity for Tata Chemicals Ltd..